Category: Lab Notes: Pharmaceutical Industry
EudraLex Volume 4 – Annex 10: Manufacture of Pressurised Metered Dose Aerosol Preparations for Inhalation
Annex 10 of EudraLex Volume 4, titled Manufacture of Pressurised Metered Dose Aerosol Preparations for Inhalation, provides specific Good Manufacturing…
EudraLex Volume 4 – Annex 12: Use of Ionising Radiation in the Manufacture of Medicinal Products
Annex 12 of EudraLex Volume 4, titled Use of Ionising Radiation in the Manufacture of Medicinal Products, provides specific guidance…
EudraLex Volume 4 – Annex 11: Computerised Systems
Annex 11 of EudraLex Volume 4, titled Computerised Systems, provides detailed Good Manufacturing Practice (GMP) guidance on the use of…
EudraLex Volume 4 – Annex 14: Manufacture of Medicinal Products Derived from Human Blood or Plasma
Annex 14 of EudraLex Volume 4, titled Manufacture of Medicinal Products Derived from Human Blood or Plasma, provides Good Manufacturing Practice…
EudraLex Volume 4 – Annex 15: Qualification and Validation
Annex 15 of EudraLex Volume 4, titled Qualification and Validation, provides detailed Good Manufacturing Practice (GMP) guidance for the qualification of…
EudraLex Volume 4 – Annex 16: Certification by a Qualified Person and Batch Release
Annex 16 of EudraLex Volume 4, titled Certification by a Qualified Person and Batch Release, outlines the Good Manufacturing Practice…
EudraLex Volume 4 – Annex 17: Real Time Release Testing and Parametric Release
Annex 17 of EudraLex Volume 4, titled Real Time Release Testing and Parametric Release, provides guidance on the use of modern…
EudraLex Volume 4 – Annex 2: Manufacture of Biological active substances and Medicinal Products for Human Use
Annex 2 of EudraLex Volume 4, titled Manufacture of Biological Active Substances and Medicinal Products for Human Use, provides specific…
EudraLex Volume 4 – Annex 1: Manufacture of Sterile Medicinal Products
Annex 1 of EudraLex Volume 4 is a cornerstone document within the European Union’s Good Manufacturing Practice (GMP) guidelines, providing…
EudraLex Volume 4
EudraLex Volume 4 is a critical component of the European Union’s regulatory framework for the manufacture of medicinal products for…
U.S. FDA 21 CFR Part 600
21 CFR Part 600, titled Biological Products: General, is a key component of the U.S. Food and Drug Administration’s (FDA)…
U.S. FDA 21 CFR Part 212
21 CFR Part 212, titled Current Good Manufacturing Practice for Positron Emission Tomography Drugs, is a specialized section of the…
U.S. FDA 21 CFR Part 314
21 CFR Part 314, titled Applications for FDA Approval to Market a New Drug, is a critical component of the…
U.S. FDA 21 CFR Part 211
21 CFR Part 211, titled Current Good Manufacturing Practice for Finished Pharmaceuticals, is a core regulation enforced by the U.S….
U.S. FDA 21 CFR Part 210
21 CFR Part 210, titled Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General, is a…